Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding
Open Access
- 1 February 2010
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (7), 4826-4836
- https://doi.org/10.1074/jbc.m109.081828
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Dependence of antibody-mediated presentation of antigen on FcRnProceedings of the National Academy of Sciences, 2008
- Anti-serum albumin domain antibodies for extending the half-lives of short lived drugsProtein Engineering, Design and Selection, 2008
- Biodistribution and tumor imaging of an anti-CEA single-chain antibody–albumin fusion proteinNuclear Medicine and Biology, 2008
- Over‐expression of the bovine FcRn in the mammary gland results in increased IgG levels in both milk and serum of transgenic miceImmunology, 2007
- Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodiesProceedings of the National Academy of Sciences, 2006
- A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsJournal of Hepatology, 2006
- Albumin Binding to FcRn: Distinct from the FcRn−IgG InteractionBiochemistry, 2006
- Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levelsNature Biotechnology, 2005
- Conferring the Binding Properties of the Mouse MHC Class I-related Receptor, FcRn, onto the Human Ortholog by Sequential Rounds of Site-directed MutagenesisJournal of Molecular Biology, 2005
- Human IgG subclass pattern of inducing complement‐mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentrationEuropean Journal of Immunology, 1991